Healthy Mom, Healthy Baby: Keys to a Successful Postpartum Care Delivery Reform Project

The research team at the Blavatnik Family Women’s Health Institute includes, from left: Mikhalya Brown, Ashaki Smith, Heather Reis, Amy Balbierz, and Naissa Piverger.

Childbirth is the number one reason for hospital admissions in the United States. As a result, postpartum care offers a window of opportunity to affect the current and future health of underserved women.

There are significant disparities in the receipt of postpartum care: Approximately 60 percent of Medicaid-insured women attend their postpartum visit, whereas approximately 80 percent of commercially insured women go to their visit. This postpartum visit is an important “check-in” for mom’s current health status, both physically and emotionally. But it is also a time to discuss long-term management for chronic conditions (such as hypertension, diabetes, and depression); improve health prior to future pregnancies; and link women to the primary health care system.

The Icahn School of Medicine at Mount Sinai partnered with Healthfirst (a Medicaid managed care organization and the largest insurer of Medicaid deliveries at the Mount Sinai Health System) and a multidisciplinary team of experts in obstetrics, health economics, and disparities to design an intervention to improve care and reduce disparities in care for high-risk women.

Amy Balbierz, MPH, is a program manager in the Department of Population Health Science and Policy and for the Blavatnik Family Women’s Health Research Institute.

The payment system redesign included a cost-sharing arrangement between the Health System and Healthfirst to cover the cost of case manager staff (social worker and care coordinator) and clinician education, and small financial incentives. After completion of this intervention, researchers concluded that it had a significant effect on postpartum visit rates among enrolled Medicaid-eligible mothers at The Mount Sinai Hospital. The project, “Reducing disparities in care for high-risk postpartum women through redesign of payment and delivery systems,” was funded by the Robert Wood Johnson Foundation.

Here are five reasons why the project was successful:

1.This care delivery project integrates evidence-based techniques. It prepares and educates women about physical and emotional symptoms of postpartum depression, gestational diabetes, and hypertension; bolsters social support and self-management; increases access to community resources; and reduces barriers to follow-up care. Our patient education materials, written in both English and Spanish, were simple and reinforced the importance of women’s health: “Remember, nearly all women will have some issue or problem after their delivery. Pregnancy and delivery demand a lot from you and your body. Go to your postpartum visit to check in on your health, to ask questions, to control issues, and to prevent issues from becoming problems.”

2. We tested the research materials prior to the rollout of the intervention. Material was pilot tested with women who were attending their postpartum visit. The new moms were asked to provide their understanding of the patient education materials and feedback on how to improve them. The materials were updated based upon the postpartum mothers’ feedback, and several of them stated they wished they had received this information during their own postpartum hospital stay.

3. The research team provided outreach to all clinical and non-clinical providers who came into contact with the patients, to ensure they knew about the who, what, why, and how of these reforms to the care delivery system. We also shared the specific aims of the intervention and stressed why it is important with staff at community health centers that provide obstetrics care. We met with everyone: obstetricians/gynecologists, maternal fetal medicine specialists, psychiatrists, nurse midwives, physician assistants, residents, postpartum nurses, lactation consultants, medical assistants, front desk staff, schedulers/registrars, obstetrics social workers, and administrative directors. We have found that staffs are very appreciative of this outreach because it acknowledges their critical roles in patient care. An informed and educated staff is much more likely to partner in the shared care delivery goals if they have a seat at the table.

4. We developed a dedicated multidisciplinary team of frontline staff through consistent and ongoing training. The personnel conducting the intervention truly cared about reducing racial/ethnic disparities in maternal and neonatal outcomes. Weekly team meetings allowed staff to discuss and monitor the status of recruitment and retention efforts, intervention delivery (including postpartum visit rates, home visits for high blood pressure, reminders for fasting glucose at the postpartum visit for mothers with gestational diabetes, and resources and follow-up for mothers with depressive symptoms), and patient outcomes. These regular check-ins reinforced the importance of the delivery change process and helped staff feel more confident and address challenges.

5.We followed up with patients and provided continuity in care. New moms are busy. They have many competing demands, including but not limited to, juggling physical and emotional postpartum symptoms with caring for their newborn, other children, and adult family members. They are often trying to do all of this while struggling with sleep deprivation, transportation challenges, and unstable home or work environments. For these reasons, the study had multiple touchpoints with postpartum women: during the hospital stay; a two-week follow-up call; a three-week survey call for data collection to assess various postpartum issues (such as physical and emotional symptoms, self-confidence/management skills, social support); postpartum visit reminder calls; and another survey at six-months. The team was sensitive to the patients’ time and energy constraints by providing options to complete the survey by phone at a time convenient to them; by email; by mail (providing a self-addressed stamped envelope); or in-person at their postpartum visits. In addition, the team care coordinator tried to meet in-person with new mothers who received their care at the hospital clinic. This familiar face and continuity built trust and patient engagement among a group of high-risk postpartum women.

In sum, it is very beneficial to implement a patient-focused program of health care starting at the mother’s hospital stay for delivery. This is a window of opportunity that should not be missed in order to set families on a positive course of health from baby’s day one.

Amy Balbierz, MPH, is a program manager in the Department of Population Health Science and Policy and for the Blavatnik Family Women’s Health Research Institute. She has worked alongside Elizabeth Howell, MD, MPP, the founding Director of The Blavatnik Family Women’s Health Research Institute at the Icahn School of Medicine at Mount Sinai, on her NIH and RWJF funded research for the last 10 years.

The Preventing Maternal Deaths Act of 2018 and Why it is Important

The United States is the only first-world country where maternal mortality rates are rising. The number of maternal deaths in the United States has risen from 674 in 1990 to 1063 in 2015, and the maternal mortality ratio, the number of maternal deaths per 100,000 live births, has increased from 16.9 to 26.4 in the same years. This trend is disproportionately affecting black and Hispanic women, with increased rates for both maternal mortality and severe maternal morbidity compared to white women.

The severity of the situation has been publicized in the media and grabbed the attention of elected officials in Washington, who last year passed the Preventing Maternal Deaths Act.

On December 21, 2018, this act was signed into law to establish a federal infrastructure to collect data on every maternal death in every state to carefully review each of the contributing factors leading up to the death and all the data on it to establish strategies and best practices for prevention. But questions remain, and the topic is bound to arise during the upcoming elections.

The Preventing Maternal Deaths Act allocated federal funds and directed the U.S. Department of Health and Human Services to establish a program that directs the funds to five crucial tasks:

  1. Review all maternal deaths
  2. Establish and sustain a Maternal Mortality Review Committee (MMRC) in every state
  3. Develop for every state a plan for ongoing health care provider education to improve the quality of maternal care, the dissemination of findings, and the implementation of recommendations
  4. Distribute Maternal Mortality Review Information Applications (MMRIA) to every state MMRC
  5. Provide public disclosure of information found in these review committees in the form of state reports

The passage of this act occurred due to the increasing rate of maternal deaths, their high preventability, and a shortage of reliable data. The goal of the new law is to standardize how each state handles maternal deaths in order to collect the best data available to establish recommendations and policies to prevent maternal death.

Anna Kheyfets is a Clinical Research Coordinator in the Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai.

An example of standardization is the creation of the Maternal Mortality Review Information Application (MMRIA) by the Centers for Disease Control and Prevention (CDC). Many states already have review committees, but there is great variability across states, resulting in data that is missing or not comprehensive. Not all states use the same definitions of maternal death or the contributing factors, nor do they have a common source of contributing factors or causes of death available for selection in their reviews.

While contributing factors can range from comorbidities to delay in treatment on the part of the provider, the very definition of what classifies a maternal death is still up for debate. Some review committees, along with the general MMRIA form itself that has been implemented by 33 states thus far, divide these deaths into “pregnancy-related” and “pregnancy-associated.”

If a woman was pregnant at the time of her death, or died up to one year after the termination of the pregnancy, this would fall into the umbrella category of pregnancy-associated. (The duration post-partum that is considered pregnancy-associated is another contested factor across varied definitions of maternal death.)

If the death occurs from a direct pregnancy complication or a sequence of events that occurs from pregnancy, such as the aggravation of an unrelated condition by the physiologic effects of pregnancy, then this death is pregnancy-related. If the death is not related to her pregnancy, then it is still pregnancy-associated but not related.

However, there is variation as to how maternal deaths are classified as pregnancy-related or not. Due to the lack of standardization, opportunities for prevention are difficult to identify, though we know they exist. With the MMRIA and the federal infrastructure behind the MMRCs, the CDC can identify solutions to improve health care quality and outcomes for mothers.

Several 2020 Democratic presidential candidates have already spoken out on policies that could reduce maternal mortality. There will be much more on this topic to look out for during these primaries.

Anna Kheyfets is a Clinical Research Coordinator in the Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai. Her work focuses  on hospital quality and racism and discrimination in maternal and child health care.

The Child Malnutrition Crisis in Haiti

Haiti is the poorest country in the Western Hemisphere and has one of the highest infant and maternal mortality rates. Naissa Piverger, MPH, a Clinical Research Coordinator in the Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai, was born in Haiti, speaks the languages, and understands what it means to live below the poverty line. In this post, she comments on the significant challenges many women in Haiti face obtaining proper health care for themselves and those they care for.

Naissa Piverger, MPH, is a Clinical Research Coordinator in the Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai.

I grew up on a farm in a rural area in Haiti with my grandparents. We had limited resources, including access to necessities, but my grandmother managed to not only feed us, but also her surrounding neighbors.

Fast-forward seventeen years later, my parents and I immigrated to the United States for a better life.

My early educational experience in Haiti was vastly different from what I experienced in the United States.  I appreciate having these diverse perspectives as it allows me to have a broader worldview. Unfortunately, through the years, I often watched helplessly from a distance, as natural and man-made calamities caused people in my birth country to suffer.

After the 2010 earthquake, I had the opportunity to visit Haiti and witness the aftermath of these natural disasters.

During my visit, I reconnected with one of my neighbors.  Marie – a mother of seven children, including three she adopted – came to pick up vegetables from my grandmother’s garden. Surprised to see me, she noted “My goodness! Look how tall you’ve grown.”

I smiled and hugged her, noticing that she was holding a baby in a shawl wrapped around her. In addition to her own children, Marie was now caring for the three children of a friend who trusted her to do so after her death.  She confided in me about the struggles to feed and maintain the health of her children.

She stated, “There are no jobs, no food, and no medical infrastructure. If I want to take my kids to see a doctor, I would have to have the money upfront or else they will not see them. Haiti is polluted by political vagabonds, and they are not doing anything to help us, and as mothers if we are not strong enough for our kids, then who will be strong for them?”

Marie’s eldest child is a 14-year-old named Jessica. Marie taught Jessica to cook as a young child because in Haiti, cooking is a means of survival. “If something happens to me, I want her to be able to help her brothers and sisters,” she explained.

She mentioned that there were hundreds of women in her position: uncertain of when their next meal will be.  Many of these women relied on the rainy season to help with the growth of their crops and fruits, never losing faith in God when things did not go as planned.

“Malnutrition in childhood and pregnancy poses a serious threat to childhood survival and long-term well-being. Given this reality, the pressure for many women in Haiti is great as they manage the health of themselves and those they care for,” says Naissa Piverger, MPH.

My experience with Marie was truly rewarding and valuable. I was fortunate to have learned about the perseverance that carried her and many others despite the challenges they faced over the years.

According to USAID, 22 percent of the population in Haiti, including 264,000 children under five, suffer from chronic malnutrition (stunting or low height-for-age) and 66 percent, or 792,000 children under five, suffer from anemia in Haiti. The country’s political instability and extreme poverty leave the residents vulnerable to disasters. The continued exposure to poor infrastructure, food insecurity, natural disasters, and communicable diseases continues to make the population of Haiti at risk for acute and chronic malnutrition.

Malnutrition in childhood and pregnancy poses a serious threat to childhood survival and long-term well-being.  Given this reality, the pressure for many women in Haiti is great as they manage the health of themselves and those they care for.

Naissa Piverger, MPH, is a Clinical Research Coordinator in the Department of Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai, where she focuses on maternal and child health. She is working on a first author manuscript examining the barriers and facilitators of active surveillance for prostate cancer. She is among the top four individuals selected to present manuscripts at the American Public Health Association’s Annual Meeting and Expo in the fall of 2019.

Elizabeth Howell, MD, MPP, at TEDMED 2018: How to Improve Care for Pregnant Women

Every year, between 700 and 900 women suffer a pregnancy-related death in the United States. Even more concerning is that a significant portion of these deaths are preventable.

In addition, for every death, more than a hundred women experience a severe pregnancy complication, such as a blood clot, blood transfusion, a hemorrhage, or a seizure during their delivery hospitalization. And significant racial disparities exist in both rates of maternal deaths and severe complications related to pregnancy.

In November 2018, Elizabeth Howell, MD, MPP, the founding Director of The Blavatnik Family Women’s Health Research Institute  at the Icahn School of Medicine at Mount Sinai, gave a TEDMED talk that explored maternal mortality, severe complications of pregnancy, and race in the United States.

“The shocking thing is that our maternal mortality rate in the United States is actually higher than all other high-income countries, and the numbers are far worse for women of color. Our rate of maternal deaths has actually increased over the last decade while other countries have reduced their rates. And here’s the biggest paradox of all: we spend more on health care than any other country in the world.”

In her talk, Dr. Howell, who is also Vice Chair of Research and Professor of Obstetrics, Gynecology and Reproductive Science, and Professor of Population Health Science and Policy, describes current statistics, the magnitude of the racial disparities that exist, and national efforts currently in place aimed at reducing maternal death, severe complications and disparities.

Message from the Director: Advancing Science in Women’s Health

The Blavatnik Family Women’s Health Research Institute at the Icahn School of Medicine at Mount Sinai was created through a generous donation by the Blavatnik Family and co-sponsored by the Department of Obstetrics, Gynecology, and Reproductive Science and the Department of Population Health Science and Policy. The Institute was founded to advance and promote research related to women’s health across the life span, as well as to advocate for quality health care for all women regardless of race, ethnicity, sexual orientation, gender, or age.

Our aim is to create and continuously expand on research in key areas affecting the health of all women, including mental health and depression; LGBTQ+ health; gynecological oncology and global health; disparities and health equity research; maternal and infant morbidity and mortality; reproductive endocrinology and fertility; and quality of care. We have a faculty of public health scholars, physician-scientists, data analysts, and experts in a range of fields in women’s health dedicated to fulfilling this goal.

Our Institute is committed to advancing science in women’s health. Our goal is to optimize quality of care for women across the life span and to narrow gaps in treatment and outcomes in underserved populations. While my research addresses quality of care and racial/ethnic disparities in maternal and child health, my colleagues’ research portfolios span the spectrum of women’s health from pre-adolescence to post-menopause.

There has been tremendous growth in advocacy, educational programs, and specialties in women’s health, but there is still much more to do. More than 50,000 women each year suffer severe pregnancy-related complications in the United States; more than 80,000 women are affected annually by ovarian and endometrial cancer; and one in eight women suffer major depression in their lifetime. Plus, many of these conditions vary widely by socioeconomic status, race, and ethnicity, creating large disparities in women’s health.

Through our Institute’s rigorous interdisciplinary research program, we aim to improve quality of care and to alleviate those disparities. Together we are committed to improving the health and well-being of women in New York City and beyond.

The goal of this blog is to bring evidence-based research on women’s health to the public, to place important issues affecting all women to the forefront, to highlight health inequities in women’s health, and to promote sustainable solutions that advance clinical care and narrow disparities. In this blog, we will share new research in women’s health, new policies affecting women’s health, and personal stories of women and their caregivers navigating the U.S. health care system.

We look forward to sharing our passions and knowledge.

Elizabeth A Howell, MD, MPP
Professor of Population Health Science & Policy
Professor of Obstetrics, Gynecology, and Reproductive Science
Director, Blavatnik Family Women’s Health Research Institute
System Vice Chair for Research, Dept. of Obstetrics Gynecology, and Reproductive Science
Associate Dean for Academic Development
Icahn School of Medicine at Mount Sinai

 

Inaugural Symposium Explores Women’s Health

From left: Lynn Roberts, PhD, Assistant Dean of Student Affairs and Alumni Relations, City College of New York; Andrea Dunaif, MD; Veerle Bergink, MD, PhD; Laura E. Riley, MD; Elizabeth A. Howell, MD, MPP; Vivian Pinn, MD; Michael Brodman, MD, the Ellen and Howard C. Katz Chair of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai; Lynne Richardson, MD, Vice Chair for Academic, Research, and Community Programs, Icahn School of Medicine at Mount Sinai; Susan Domchek, MD, Executive Director, Basser Center for BRCA, Penn Medicine; and Stephanie V. Blank, MD, Director of Gynecologic Oncology, Mount Sinai Health System.

Why are more women than men hospitalized for schizophrenia after age 50? How should a bipolar pregnant woman be medicated? What should the study of women’s health encompass?

These were some of the questions posed recently by leading physician-scientists at the inaugural symposium of The Blavatnik Family Women’s Health Research Institute at the Icahn School of Medicine at Mount Sinai—“Cutting-Edge Topics in Women’s Health.”

The keynote speaker of the symposium, held in Davis Auditorium, was Vivian Pinn, MD, the first Director of the Office of Research on Women’s Health at the National Institutes of Health (NIH). She delivered a lesson on the not-so-distant past, saying, “Until the 1990s, most women’s health research was related to the reproductive system or the breasts—what is known as ‘bikini medicine’—and most studies of conditions that affect both men and women were conducted only in men.”

The symposium focused on issues such as equity in research, and health conditions that end women’s lives prematurely or significantly reduce their quality of life.

“These topics are a reflection of the broad research portfolio of The Blavatnik Family Women’s Health Research Institute and our strong commitment to health equity,” said its founding Director, Elizabeth A. Howell, MD, MPP, Vice Chair of Research and Professor of Obstetrics, Gynecology and Reproductive Science, and Professor of Population Health Science and Policy at the Icahn School of Medicine. The Blavatnik Family Foundation in 2018 provided a $10 million gift to establish the Institute and its clinical counterpart, The Blavatnik Family – Chelsea Medical Center at Mount Sinai. Dr. Howell said she is grateful to the family for their generous gift and support of the Institute.

Mental health is one area in which sex differences are clear, said Veerle Bergink, MD, PhD, Professor of Psychiatry, and Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine. Dr. Bergink said women are particularly vulnerable during pregnancy, which she and other panelists called a “stress test” that can trigger underlying autoimmune or mental health disorders. Her evidence-based treatment strategy, published in the December 2016 American Journal of Psychiatry, concluded that women who have bipolar disease or previous postpartum psychosis could avoid a relapse if they are treated with lithium soon after delivery.

An important area for further study is schizophrenia in post-menopausal women, Dr. Bergink said. Until age 50, the disorder is more prevalent in men, but there is a sudden turning point after 50 when more women are hospitalized for schizophrenia than men. An “estrogen hypothesis” proposes that the hormone has a protective effect that declines after menopause. “But we know very little about this,” Dr. Bergink said. ”Most of the schizophrenia research over the last 30 years has investigated men, and very little has focused on women.”

Another area for further study is the influence of pregnancy complications on women’s health in later life, said Laura E. Riley, MD, Professor and Chair of Obstetrics and Gynecology, Weill Cornell Medicine. Dr. Riley said that 7 to 10 percent of pregnant women in the United States are diagnosed with gestational diabetes and up to 9 percent contract preeclampsia, characterized by dangerously high blood pressure. Studies have shown that such complications are associated with cardiovascular disease and type 2 diabetes later in the lives of these women, Dr. Riley said, and there are many medical and behavioral interventions to be explored.

“For those of you looking for research projects, these might be good ones,” she said, “because I don’t think this story is over.”

Attendees received expert grant-writing advice from Andrea Dunaif, MD, Chief of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease, and the Lillian and Henry M. Stratton Professor of Molecular Medicine, Icahn School of Medicine, whose groundbreaking research into diabetes and polycystic ovary syndrome has been continuously funded by the NIH since 1985. Dr. Dunaif also addressed more complex challenges, such as adhering to the “sex as a biological variable” policy, which since 2016 has required researchers to factor sex into the design, analysis, and reporting of any study that involves humans or vertebrate animals. 

“A little-known fact is that only the males get diabetes in almost all animal models of diabetes. Studies have found that the protection of female sex—both hormonal and chromosomal sex—is powerful,” Dr. Dunaif said. “But that begs the question of why? This is very important scientific question. I’m sure there are many more disease models in which there are major sex differences, and those should be studied.” 

Inclusive research is a key legacy of Dr. Pinn, who retired in 2011. The office she led was established in 1990, after four congresswomen called for action on women’s health research. Since then, studies have documented sex differences in the prevalence, age of onset, and severity of autoimmune diseases, depressive disorders, diabetes, and cardiovascular disease. “And there is still much to learn,” she said, “about the process of moving from discovery to treatment.”

Pin It on Pinterest